This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Ethanolamine-phosphate on the second mannose is a preferential bridge for some GPI-anchored proteins.
EMBO reports · 2022
A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome.
European journal of human genetics : EJHG · 2020
Genomic study of severe fetal anomalies and discovery of GREB1L mutations in renal agenesis.
Genetics in medicine : official journal of the American College of Medical Genetics · 2018
Latest funding
- $1,074,825
Role of fibronectin in skeletal development and associated disease
CIHR · 2024 · Principal investigator
- $293,643
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
CIHR · 2022 · Co-investigator
- $1,174,568
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
CIHR · 2022 · Co-investigator
3 publications.
Ethanolamine-phosphate on the second mannose is a preferential bridge for some GPI-anchored proteins.
Ishida M, Maki Y, Ninomiya A, Takada Y, Campeau P, Kinoshita T, Murakami Y
A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome.
Drivas TG, Li D, Nair D, Alaimo JT, Alders M, Altmüller J, Barakat TS, Bebin EM, Bertsch NL, Blackburn PR, Blesson A, Bouman AM, Brockmann K, Brunelle P, Burmeister M, Cooper GM, Denecke J, Dieux-Coëslier A, Dubbs H, Ferrer A, Gal D, Bartik LE, Gunderson LB, Hasadsri L, Jain M, Karimov C, Keena B, Klee EW, Kloth K, Lace B, Macchiaiolo M, Marcadier JL, Milunsky JM, Napier MP, Ortiz-Gonzalez XR, Pichurin PN, Pinner J, Powis Z, Prasad C, Radio FC, Rasmussen KJ, Renaud DL, Rush ET, Saunders C, Selcen D, Seman AR, Shinde DN, Smith ED, Smol T, Snijders Blok L, Stoler JM, Tang S, Tartaglia M, Thompson ML, van de Kamp JM, Wang J, Weise D, Weiss K, Woitschach R, Wollnik B, Yan H, Zackai EH, Zampino G, Campeau P, Bhoj E
Genomic study of severe fetal anomalies and discovery of GREB1L mutations in renal agenesis.
Boissel S, Fallet-Bianco C, Chitayat D, Kremer V, Nassif C, Rypens F, Delrue MA, Dal Soglio D, Oligny LL, Patey N, Flori E, Cloutier M, Dyment D, Campeau P, Karalis A, Nizard S, Fraser WD, Audibert F, Lemyre E, Rouleau GA, Hamdan FF, Kibar Z, Michaud JL
Role of fibronectin in skeletal development and associated disease
Principal investigators: Reinhardt, Dieter P; Campeau, Philippe M
Keywords: Chondrogenesis; Connective Tissue Disorder; Differentiation; Extracellular Matrix; Fibronectin; Induced Pluripotent Stem Cells; Lineage Tracing; Mesenchymal Stem Cells; Recombinant Proteins
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
Principal investigators: Mitchell, John J; Smith, Maureen M; Inbar-Feigenberg, Michal; Jain, Shailly; Polgreen, Lynda; Potter, Elizabeth K
Keywords: Growth; Mucopolysaccharidoses; Pain; Quality Of Life; Rare Disease; Tnf-Alpha
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
Principal investigators: Mitchell, John J; Smith, Maureen M; Inbar-Feigenberg, Michal; Jain, Shailly; Polgreen, Lynda; Potter, Elizabeth K
Keywords: Growth; Mucopolysaccharidoses; Pain; Quality Of Life; Rare Disease; Tnf-Alpha
A novel BAFopathy syndrome: Functional genetics using human stem cells and gene editing technologies
Principal investigators: Ernst, Carl P
Keywords: Actl6b; Genetics; Neurodevelopment; Neuroscience
Development of Enzyme Replacement Therapy for Urea Cycle Defects
Principal investigators: Campeau, Philippe M
Keywords: Enzyme Replacement Therapy; Genetic Disorders; Inborn Errors Of Metabolism; Protein Transduction; Urea Cycle Defects
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Philippe Campeau and Philippe Campeau: 3 shared papers
- David Dyment and David Chitayat: 1 shared paper
- David Dyment and Zoha Kibar: 1 shared paper
- David Dyment and Philippe Campeau: 1 shared paper
- David Dyment and Philippe Campeau: 1 shared paper
- David Chitayat and Zoha Kibar: 1 shared paper
- David Chitayat and Philippe Campeau: 1 shared paper
- David Chitayat and Philippe Campeau: 1 shared paper
- Zoha Kibar and Philippe Campeau: 1 shared paper
- Zoha Kibar and Philippe Campeau: 1 shared paper
- Anatomy and Cell Biology
- Pediatrics
- Computer Science
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.